Expert Review Of Anticancer Therapy SCISCIE

Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches.

Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care.

Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections:

Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results

Article Highlights – an executive summary of the author’s most critical points.

抗癌治疗专家评论 (ISSN 1473-7140) 就癌症治疗的主要趋势提供专家评估和评论，并强调新的治疗和诊断方法的表现。

覆盖范围包括肿瘤管理、新型药物、抗癌药物和化疗、生物治疗、癌症疫苗、治疗适应症、生物标志物和诊断以及治疗指南。所有文章都经过严格的同行评审，该杂志对癌症治疗的决策做出了重要贡献。

每条评论的全面覆盖由独特的专家评论格式补充，包括以下部分：

专家意见 - 对文章中提供的数据的个人看法，对未来可能重要的发展的讨论，以及随着进一步研究产生更详细的结果而可能变得令人兴奋的研究途径

文章重点——作者最关键点的执行摘要。

该刊已被国际权威数据库SCI、SCIE收录，是国际顶级期刊。该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-肿瘤学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2022年影响因子为3.3，平均审稿速度为偏慢,4-8周，近三年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。